Correlation Between Keyarch Acquisition and Bellevue Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Keyarch Acquisition and Bellevue Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Keyarch Acquisition and Bellevue Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Keyarch Acquisition and Bellevue Life Sciences, you can compare the effects of market volatilities on Keyarch Acquisition and Bellevue Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Keyarch Acquisition with a short position of Bellevue Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Keyarch Acquisition and Bellevue Life.

Diversification Opportunities for Keyarch Acquisition and Bellevue Life

-0.18
  Correlation Coefficient

Good diversification

The 3 months correlation between Keyarch and Bellevue is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding Keyarch Acquisition and Bellevue Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bellevue Life Sciences and Keyarch Acquisition is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Keyarch Acquisition are associated (or correlated) with Bellevue Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bellevue Life Sciences has no effect on the direction of Keyarch Acquisition i.e., Keyarch Acquisition and Bellevue Life go up and down completely randomly.

Pair Corralation between Keyarch Acquisition and Bellevue Life

If you would invest  1,047  in Bellevue Life Sciences on September 12, 2024 and sell it today you would earn a total of  83.00  from holding Bellevue Life Sciences or generate 7.93% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy0.4%
ValuesDaily Returns

Keyarch Acquisition  vs.  Bellevue Life Sciences

 Performance 
       Timeline  
Keyarch Acquisition 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Keyarch Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical indicators, Keyarch Acquisition is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Bellevue Life Sciences 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Bellevue Life Sciences are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, Bellevue Life is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Keyarch Acquisition and Bellevue Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Keyarch Acquisition and Bellevue Life

The main advantage of trading using opposite Keyarch Acquisition and Bellevue Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Keyarch Acquisition position performs unexpectedly, Bellevue Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bellevue Life will offset losses from the drop in Bellevue Life's long position.
The idea behind Keyarch Acquisition and Bellevue Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites